dc.contributor.author | Castanon, Alejandra | |
dc.contributor.author | Rebolj, Matejka | |
dc.contributor.author | Burger, Emily Annika | |
dc.contributor.author | de Kok, Inge M. C. M. | |
dc.contributor.author | Smith, Megan A. | |
dc.contributor.author | Hanley, Sharon J. B. | |
dc.contributor.author | Carozzi, Francesca Maria | |
dc.contributor.author | Peacock, Stuart | |
dc.contributor.author | O'Mahony, James F. | |
dc.date.accessioned | 2023-01-25T12:12:01Z | |
dc.date.available | 2023-01-25T12:12:01Z | |
dc.date.issued | 2021-07-01 | |
dc.identifier.citation | Castanon , A , Rebolj , M , Burger , E A , de Kok , I M C M , Smith , M A , Hanley , S J B , Carozzi , F M , Peacock , S & O'Mahony , J F 2021 , ' Cervical screening during the COVID-19 pandemic : optimising recovery strategies. ' , The Lancet Public Health , vol. 6 , no. 7 , pp. e522-e527 . https://doi.org/10.1016/S2468-2667(21)00078-5 | en |
dc.identifier.issn | 2468-2667 | |
dc.identifier.other | PURE: 226325426 | |
dc.identifier.other | PURE UUID: 568caf9c-7b3e-4695-bd62-edf1f1eff0f5 | |
dc.identifier.other | RIS: urn:88EA5D1EDBDD4AF4CE7F4CB6E0A2D2D7 | |
dc.identifier.other | ORCID: /0000-0002-7554-004X/work/127304252 | |
dc.identifier.other | Scopus: 85108554277 | |
dc.identifier.uri | https://hdl.handle.net/2164/19896 | |
dc.description | Acknowledgments This work was done on behalf of the Screening Working Group of the COVID-19 and Cancer Global Modelling Consortium (CCGMC) and we acknowledge all members of the CCGMC Steering Committee, Secretariat, and Working Group 2. This work was supported by Ireland's Health Research Board (grant number EIA-2017–054 to JFOM), the National Health and Medical Research Council (Australia; grant APP1159491 to MAS), Cancer Research UK (grant number C8162/A27047 to MR and AC), Cancer Institute NSW (ECF181561 to MAS), National Institutes of Health (USA; U01CA199334 to EAB), Norwegian Cancer Society (#198073 to EAB), and the National Cancer Centre (Japan; 31-A-20 to SJBH). These funders had no role in directing or the writing of the manuscript, or the decision to submit for publication. | en |
dc.format.extent | 6 | |
dc.language.iso | eng | |
dc.relation.ispartof | The Lancet Public Health | en |
dc.rights | Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. https://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | Female | en |
dc.subject | Humans | en |
dc.subject | *COVID-19 | en |
dc.subject | *Early Detection of Cancer | en |
dc.subject | *Mass Screening | en |
dc.subject | *Pandemics | en |
dc.subject | Health Services Accessibility | en |
dc.subject | Healthcare Disparities | en |
dc.subject | SARS-CoV-2 | en |
dc.subject | Uterine Cervical Neoplasms/*diagnosis | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | Cervical screening during the COVID-19 pandemic : optimising recovery strategies. | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Women’s Health Research | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1016/S2468-2667(21)00078-5 | |
dc.identifier.vol | 6 | en |
dc.identifier.iss | 7 | en |